Ami Fadia

Work

Analyst Ami Fadia works at LEERINK and is focused on the Healthcare sector with 252 price targets and ratings documented since 2018 spanning on 22 stocks. Analyst's average stock valuation to be materialised ratio is 43.71% with an average time for price targets to be met of 102.76 days.

Most recent stock forecast was given on AVDL, Avadel Pharmaceuticals plc at 21-Nov-2022.

Ami Fadia best performing recommendations are on MNK.
The best stock recommendation documented was for MNK at 9/6/2019. The price target of $2 was fulfilled within 3 days with a profit of $0.13 (6.95%) receiving and performance score of 23.17.

Average potential price target upside

AMRN ARDX AVDL BIIB HRMY HRTX JAZZ MYOV OBSV SAGE BCYC ITCI MNK MRUS NBIX TEVA ACAD AMRX MYL PCRX SGEN VTRS

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

3

$1.05 (53.85%)

5

1 months ago

5/24 (20.83%)

$8.19 (52.68%)

58

Sell

8 months ago

1/3 (33.33%)

$2.15 (12.62%)

300

Buy

9

$7.05 (361.54%)

10

9 months 2 days ago

2/8 (25%)

$4.49 (114.87%)

28

Buy

10

$8.05 (412.82%)

10

11 months 5 days ago

2/40 (5%)

$15.87 (150.77%)

3

Sell

5

11 months 21 days ago

8/12 (66.67%)

$1.07 (24.66%)

51

Show more analysts
AMRN ARDX AVDL BIIB HRMY HRTX JAZZ MYOV OBSV SAGE BCYC ITCI MNK MRUS NBIX TEVA ACAD AMRX MYL PCRX SGEN VTRS